Cancer begets venous thromboembolism, but is venous thromboembolism a risk factor for cancer?
β Scribed by R. H. WHITE
- Book ID
- 109152840
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 71 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1538-7933
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Venous thromboembolism (VTE) contributes to morbidity and mortality in cancer patients and is a frequent complication of anticancer therapy. In the current study, the frequency, risk factors, and trends associated with VTE were examined among hospitalized cancer patients
Frequency, Risk Factors, and Trends for Venous Thromboembolism Among Hospitalized Cancer Patients I n a recent issue of Cancer, Khorana et al. 1 concluded that venous thromboembolic events (VTEs) are an increasingly frequent complication of hospitalization in cancer patients. We strongly agree with